Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Researchers from Keele University have said there are multiple barriers preventing clinicians from prescribing alternative treatments for asthma patients, despite guidance calling for a move toward ...

Porush created the first metered-dose inhaler (MDI) in just two months. By March 1956, the Food and Drug Administration had approved two new aerosol drugs for asthma, as well as Porush’s device ...

AptarGroup (ATR) announced the commencement of a clinical study to validate its proprietary SmartTrack platform. The platform was developed by ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...